Shockwave Treatment of Diabetic Foot Ulcer: Step I (STUF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00954343|
Recruitment Status : Withdrawn
First Posted : August 7, 2009
Last Update Posted : March 19, 2013
Extracorporeal Shock Wave treatment is a well established treatment in orthopedics. Considerable success has been reported after treatment of various soft tissue pathologies (Tendinitis, heel spur etc). In recent years, encouraging results have been reported concerning the effect of the shock-wave on chronic wounds. It has been reported that healing time can be considerably shortened if shock-waves are applied to the wound in addition to conventional wound treatment. Yet, randomized, controlled, prospective trials are missing.
In this study, the effect of shock-waves on diabetic foot ulcer shall be assessed.
The study is composed of 5 groups of which 4 groups receive shock wave treatments (each with a different protocol). One group serves as an untreated control group. All groups get standardized wound treatment and wound dressing.
That shock-wave application protocol that shows the best results (rate of completely healed ulcer, most decrease of ulcer size) shall be tested in a further, sufficiently dimensioned, two-armed, randomized controlled trial (RCT).
|Condition or disease||Intervention/treatment||Phase|
|Chronic Diabetic Foot Ulcers||Procedure: Extracorporeal Shock Wave||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Shockwave Treatment of Diabetic Foot Ulcer. A Prospective, Controlled, Randomized Trial. Step 1|
|Study Start Date :||August 2009|
|Experimental: Group I||Procedure: Extracorporeal Shock Wave|
|Experimental: Group II||Procedure: Extracorporeal Shock Wave|
|Experimental: Group III||Procedure: Extracorporeal Shock Wave|
|Experimental: Group IV||Procedure: Extracorporeal Shock Wave|
|No Intervention: Group V|
- Percentage decrease of ulcer size twelve weeks after treatment begin (i.e. first shock wave treatment) compared to the baseline (ulcer size at first treatment)
- Rate of completely healed ulcer 6, 9 and 12 weeks after first treatment
- Percentage decrease of ulcer size 6 and 9 weeks after first treatment
- Tissue oxygen concentration after shock wave treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00954343
|Klinik für Orthopädie und Unfallchirurgie, Klinikum rechts der Isar|
|Munic, Bavaria, Germany, 81675|
|Principal Investigator:||Hans Gollwitzer, PD Dr., CCRP||Klinik für Orthopädie und Unfallchirurgie Klinikum rechts der Isar|